A detailed history of Orbimed Advisors LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,573,000 shares of VIR stock, worth $28.6 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
3,573,000
Previous 2,320,102 54.0%
Holding current value
$28.6 Million
Previous $20.6 Million 29.61%
% of portfolio
0.63%
Previous 0.5%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.26 - $10.7 $9.1 Million - $13.4 Million
1,252,898 Added 54.0%
3,573,000 $26.8 Million
Q2 2024

Aug 14, 2024

BUY
$7.63 - $12.66 $12.8 Million - $21.3 Million
1,680,102 Added 262.52%
2,320,102 $20.6 Million
Q1 2024

May 15, 2024

BUY
$8.6 - $11.9 $4.64 Million - $6.41 Million
539,000 Added 533.66%
640,000 $6.48 Million
Q4 2023

Feb 14, 2024

BUY
$7.76 - $10.29 $783,760 - $1.04 Million
101,000 New
101,000 $1.02 Million

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.06B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.